Skip to main content

Table 1 Basic clinical and serum biochemistry variables and their association with circulatory IL-17 concentrations

From: Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Item Values Beta Confidence interval P
Coefficient Low High
Patient # 404     
IL-17 (ng/ml) 5.57 ± 18.74     
Age (years) 59.37 ± 10.94 91.4  − 76.4 259.2 0.285
Gender-Male 249 (61.6%) 1814.3  − 1956.2 5584.8 0.345
HBV positivity 237 (58.7%)  − 1293.9  − 5019.2 2431.4 0.495
HCV positivity 128 (31.7%) 2587.2  − 1350.0 6524.4 0.197
AST (IU/L) 45.38 ± 40.61  − 2.9  − 48.2 42.5 0.900
ALT (IU/L) 39.76 ± 45.48  − 13.7  − 54.2 26.8 0.506
Bilirubin (mg/dL) 1.43 ± 5.47  − 7.4  − 344.1 329.3 0.965
AFP (ng/ml) 8.84 ± 28.99 21.6  − 41.9 85.0 0.505
Albumin (g/dL) 3.61 ± 0.44 1222.5  − 3006.3 5451.2 0.570
Total protein (g/dL) 7.21 ± 0.67  − 455.5  − 3188.5 2277.5 0.743
C3 (mg/dL) 96.42 ± 20.62  − 73.7  − 163.1 15.8 0.106
C4 (mg/dL) 19.68 ± 8.40  − 77.7  − 297.9 142.5 0.488
TSH (mU/L) 2.16 ± 4.70 29.0  − 360.5 418.5 0.884
Free T4 (ng/dL) 1.07 ± 0.26  − 2422.4  − 9503.0 4658.2 0.502
Sugar AC (mg/dL) 106.81 ± 35.66  − 14.1  − 65.8 37.7 0.593
Glycohemoglobin (%) 6.07 ± 1.33  − 447.7  − 1838.8 943.5 0.527
Insulin (mIU/L) 11.33 ± 12.31  − 103.3  − 252.6 46.1 0.175
Insulin/Sugar 0.38 ± 2.21  − 222.5  − 1128.2 683.2 0.629
HOMA-IR 2.68 ± 3.19  − 243.9  − 868.3 380.4 0.442
Apo A1 (g/L) 1.37 ± 0.30  − 4431.4  − 10,512.7 1649.8 0.153
Uric Acid (mg/dL) 5.97 ± 1.79  − 695.8  − 1730.0 338.5 0.187
HDL (mg/dL) 48.70 ± 16.27 15.9  − 97.3 129.2 0.782
VLDL (mg/dL) 20.67 ± 13.88  − 40.1  − 175.2 95.0 0.560
LDL (mg/dL) 97.35 ± 30.80  − 30.7  − 91.3 29.8 0.319
Cholesterol (mg/dL) 165.81 ± 36.85  − 26.5  − 76.8 23.8 0.302
Triglyceride (mg/dL) 104.20 ± 63.69  − 8.5  − 37.7 20.6 0.565
Ferritin (ng/mL) 274.01 ± 445.64 1.0  − 3.2 5.1 0.651
Ceruloplasmin (mg/dL) 24.79 ± 5.43 15.1  − 327.7 358.0 0.931
Iron (ug/dL) 119.29 ± 55.86 24.9  − 8.1 57.8 0.139
TIBC (ug/dL) 326.69 ± 56.80  − 13.2  − 45.7 19.3 0.424
UIBC (ug/dL) 200.22 ± 84.92  − 14.3  − 42.0 13.3 0.309
  1. “HBV positivity” include (a) HBV without HCV, n = 219; and (b) HBV, HCV co-infection, n = 18
  2. “HCV positivity” include (a) HCV without HBV, n = 110; and (b) HBV, HCV co-infection, n = 18